"Dihematoporphyrin Ether" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The purified component of HEMATOPORPHYRIN DERIVATIVE, it consists of a mixture of oligomeric porphyrins. It is used in photodynamic therapy (HEMATOPORPHYRIN PHOTORADIATION); to treat malignant lesions with visible light and experimentally as an antiviral agent. It is the first drug to be approved in the use of PHOTODYNAMIC THERAPY in the United States.
| Descriptor ID |
D017323
|
| MeSH Number(s) |
D03.383.129.578.840.500.462.400.200 D03.633.400.909.500.462.400.200 D04.345.783.500.462.400.200 D23.767.727.462.400.200
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dihematoporphyrin Ether".
Below are MeSH descriptors whose meaning is more specific than "Dihematoporphyrin Ether".
This graph shows the total number of publications written about "Dihematoporphyrin Ether" by people in this website by year, and whether "Dihematoporphyrin Ether" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dihematoporphyrin Ether" by people in Profiles.
-
Safety and Feasibility of Photodynamic Therapy for Ablation of Peripheral Lung Tumors. J Bronchology Interv Pulmonol. 2023 Apr 01; 30(2):135-143.
-
Photooxidative action in cancer and normal cells induced by the use of photofrin in photodynamic therapy. Folia Biol (Praha). 2008; 54(1):24-9.
-
Intracellular distribution of Photofrin in malignant and normal endothelial cell lines. Folia Biol (Praha). 2007; 53(1):7-12.
-
Cytosolic superoxide dismutase activity after photodynamic therapy, intracellular distribution of Photofrin II and hypericin, and P-glycoprotein localization in human colon adenocarcinoma. Folia Histochem Cytobiol. 2007; 45(2):93-8.
-
Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells. Biochem Biophys Res Commun. 2006 Oct 20; 349(2):549-55.
-
The influence of photodynamic therapy on apoptosis in human melanoma cell line. Folia Histochem Cytobiol. 2005; 43(3):129-32.
-
Levels of lipid peroxidation in A549 cells after PDT in vitro. Rocz Akad Med Bialymst. 2004; 49 Suppl 1:82-4.
-
Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis. Ann Surg Oncol. 2001 Apr; 8(3):254-9.
-
Phase II trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Ann Surg Oncol. 2001 Jan-Feb; 8(1):65-71.
-
Photodynamic therapy with systemic administration of photosensitizers in dermatology. J Photochem Photobiol B. 1996 Nov; 36(2):225-31.